Abstract
The paper summarizes the literature data and the authors' own investigations on cardiotropic and clinical-pharmacological properties of Mildronat. The medication normalizes energy metabolism, optimizes the functions of the heart, and improves the health state of patients with angina pectoris and cardiac insufficiency.
MeSH terms
-
Cardiovascular Agents / therapeutic use*
-
Cardiovascular Diseases / drug therapy*
-
Cardiovascular Diseases / etiology
-
Cardiovascular Diseases / metabolism
-
Energy Metabolism / drug effects*
-
Humans
-
Methylhydrazines / therapeutic use*
Substances
-
Cardiovascular Agents
-
Methylhydrazines
-
3-(2,2,2-trimethylhydrazine)propionate